ea0049ep188 | Endocrine tumours and neoplasia | ECE2017
Bursuc Anamaria
, Daniela Belceanu Alina
, Armasu Ioana
, Tirnovan Mirela
, Manolachie Adina
, Crumpei Felicia
, Ciobanu Delia
, Leustean Letitia
, Vulpoi Carmen
Introduction: Pancreatic neuroendocrine tumors (PNET) are rare, with an incidence of 1/100,000/year. Chromogranin A (CgA) is the most valuable marker in the diagnosis and monitoring of PNET. One of the disadvantages is its low specificity and the existence of a number of processes leading to an increase in its concentration, which often results in confusion and diagnostic difficulties.Case report: We present a 44-years-old female patient...